FIELD: laboratory diagnostics.
SUBSTANCE: invention relates to laboratory diagnostics, medical virology, molecular biology and epidemiology and can be used for differential diagnosis of infectious mononucleosis associated with Epstein-Barr virus and human herpes virus type 6. Substance of the method: in peripheral leukocytes of patients diagnosed with infectious mononucleosis, FADD mRNA, CIRBP transcript 2 and TRAF3 transcript 2 levels are determined and if the expression is reduced, the EBV-associated is diagnosed, and if the expression increases, the HHV-6-associated infectious mononucleosis is diagnosed.
EFFECT: invention provides an informative and evidentiary method for differential diagnosis of infectious mononucleosis.
1 cl, 3 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH TYPE 6 HUMAN HERPES VIRUS | 2019 |
|
RU2729413C1 |
| METHOD FOR PREDICTION OF SEVERITY OF EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS | 2020 |
|
RU2732010C1 |
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2732813C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF HERPES VIRUS MIXED INFECTION | 2020 |
|
RU2739854C1 |
| DIAGNOSTIC TECHNIQUE FOR SEVERE FORM OF THE EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS | 2020 |
|
RU2732012C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING WEB-ASSOCIATED TUMORS IN THE PATIENTS WITH ACUTE EBV-INFECTION | 2019 |
|
RU2707075C1 |
| METHOD OF SEARCHING FOR MOLECULAR MARKERS OF A PATHOLOGICAL PROCESS FOR DIFFERENTIAL DIAGNOSIS, MONITORING AND TARGETED THERAPY | 2019 |
|
RU2709815C1 |
| BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2720110C1 |
| METHOD FOR SIMULTANEOUS DETECTION OF LYMPHOTROPIC HERPESVIRUSES HHV6A, HHV6B, EBV AND ITS MAIN GENOTYPES EBV-1 AND EBV-2 | 2023 |
|
RU2805956C1 |
| METHOD FOR ASSESSMENT OF ACTIVITY OF INFECTION CAUSED BY HERPES TYPE 4, 5 AND 6 IN CHILDREN | 2016 |
|
RU2639593C1 |
